prostate cancer

FDA APPROVES PRODUCTION OF IMAGING AGENT THAT HELPS DETECT PROSTATE CANCER

Mayo Clinic is the first facility approved to manufacture Choline C 11 Injection
 
September 18, 2012  (Washington, D.C.) -- The U.S. Food and Drug Administration has approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.
 
Choline C 11 Injection is administered intravenously to produce an image that helps to locate specific body sites for follow-up tissue sampling and testing in men with recurrent prostate cancer.


Error message

Local news in the public interest is more important now than ever, during the COVID-19 crisis. Our reporters, as essential workers, are dedicated to keeping you informed, even though we’ve had to cancel fundraising events. Please give the gift of community journalism by donating at https://www.eastcountymedia.org/donate.